Search Results - Campias, Claudia

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial

    Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial by Vallejos, Julio, Zoni, Rodrigo, Bangher, María, Villamandos, Silvina, Bobadilla, Angelina, Plano, Fabian, Campias, Claudia, Chaparro Campias, Evangelina, Medina, Maria Fernanda, Achinelli, Fernando, Guglielmone, Hector Andres, Ojeda, Jorge, Farizano Salazar, Diego, Andino, Gerardo, Kawerin, Pablo, Dellamea, Silvana, Aquino, Antonia Cristina, Flores, Victor, Martemucci, Carolina N, Martinez, Silvina Maria, Segovia, Juan Emanuel, Reynoso, Paola Itati, Sosa, Noelia Carolina, Robledo, Mariana Elizabeth, Guarrochena, Joaquina Maria, Vernengo, Maria Mercedes, Ruiz Diaz, Natalia, Meza, Elba, Aguirre, María Gabriela

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19): a structured summary of a study protocol for a randomized controlled trial

    Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19): a structured summary of a study protocol for a randomized controlled trial by Vallejos, Julio, Zoni, Rodrigo, Bangher, Maria, Villamandos, Silvina, Bobadilla, Angelina, Plano, Fabian, Campias, Claudia, Chaparro Campias, Evangelina, Achinelli, Fernando, Guglielmone, Hector A, Ojeda, Jorge, Medina, Fernanda, Farizano Salazar, Diego, Andino, Gerardo, Ruiz Diaz, Natalia E, Kawerin, Pablo, Meza, Elba, Dellamea, Silvana, Aquino, Antonia, Flores, Victor, Martemucci, Carolina N, Vernengo, María Mercedes, Martinez, Silvina María, Segovia, Juan Emanuel, Aguirre, María Gabriela

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Clinical effect of driver mutations of JAK2, CALR, or MPL in primary myelofibrosis

    Clinical effect of driver mutations of JAK2, CALR, or MPL in primary myelofibrosis by Rumi, Elisa, Pietra, Daniela, Pascutto, Cristiana, Guglielmelli, Paola, Martínez-Trillos, Alejandra, Casetti, Ilaria, Colomer, Dolors, Pieri, Lisa, Pratcorona, Marta, Rotunno, Giada, Sant'Antonio, Emanuela, Bellini, Marta, Cavalloni, Chiara, Mannarelli, Carmela, Milanesi, Chiara, Boveri, Emanuela, Ferretti, Virginia, Astori, Cesare, Rosti, Vittorio, Cervantes, Francisco, Barosi, Giovanni, Vannucchi, Alessandro M., Cazzola, Mario

    Published in Blood
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Abnormal expression patterns of WT1-as, MEG3 and ANRIL long non-coding RNAs in CD34+ cells from patients with primary myelofibrosis and their clinical correlations

    Abnormal expression patterns of WT1-as, MEG3 and ANRIL long non-coding RNAs in CD34+ cells from patients with primary myelofibrosis and their clinical correlations by Pennucci, Valentina, Zini, Roberta, Norfo, Ruggiero, Guglielmelli, Paola, Bianchi, Elisa, Salati, Simona, Sacchi, Giorgia, Prudente, Zelia, Tenedini, Elena, Ruberti, Samantha, Paoli, Chiara, Fanelli, Tiziana, Mannarelli, Carmela, Tagliafico, Enrico, Ferrari, Sergio, Vannucchi, Alessandro M., Manfredini, Rossella

    Published in Leukemia & lymphoma
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: